Stifel Appointed as Financial Advisor for Santhera Pharmaceuticals
Stifel Financial Corp shares fell sharply, hitting a 20-day low amid broader market weakness, with the Nasdaq-100 down 1.60% and the S&P 500 down 1.04%.
Santhera Pharmaceuticals has appointed Stifel Nicolaus Europe Limited as its new corporate finance advisor, focusing on capital markets and international institutional investors. This partnership aims to enhance Santhera's visibility and attractiveness in the global market, particularly as it develops innovative medicines for rare neuromuscular diseases, including AGAMREE® (vamorolone), which has received approvals in multiple regions. The collaboration with Octavian AG will further broaden the investor base.
The appointment of Stifel as an advisor reflects the company's strategic positioning in the capital markets, although the current market conditions have led to a decline in Stifel's stock price. Investors will be watching closely how this partnership impacts Santhera's growth and market presence.
Trade with 70% Backtested Accuracy
Analyst Views on SF
About SF
About the author

- Impact on Congress: The escalating conflict in the Middle East may lead to delays in Congress's legislative activities.
- Risk to Domestic Agenda: This situation poses a threat to a significant portion of President Trump's domestic agenda.
- Surge in Gas Prices: Amid the ongoing Middle East conflict, Dutch TTF futures surged 35% on Tuesday to over 60 euros ($69.64) per megawatt-hour, with prices up approximately 76% for the week, posing significant risks to European economic growth.
- Supply Disruption Risks: Qatar halted production due to Iranian drone strikes, leading to an estimated 19% reduction in global LNG supply, which could trigger severe supply squeezes in Europe and Asia, where LNG accounts for about 25% of total gas supply.
- Economic Impact Assessment: Rising energy prices are projected to negatively impact GDP, with Goldman Sachs estimating that a sustained 10% increase in energy prices could reduce GDP by 0.2% in both the UK and euro area, while Norway may see a slight benefit.
- Asian Market Vulnerability: India sources 58% of its LNG imports from the Middle East, accounting for nearly 2% of its primary energy consumption, and Singapore's imports are 27%, highlighting the heightened risks these nations face from energy supply disruptions.
- Stock Performance Comparison: Over the past year, SF.PRC shares have shown relatively stable performance compared to common shares SF, with SF.PRC rising only 0.3% while common shares increased by 3.1%, indicating a potential growing preference among investors for common stock.
- Dividend History Overview: Stifel Financial Corporation's 6.125% Non-Cumulative Preferred Stock Series C (Symbol: SF.PRC) has a consistent dividend record, appealing to income-seeking investors and enhancing its attractiveness in the capital markets.
- Market Reaction Analysis: In Monday trading, SF.PRC shares saw a slight increase, reflecting stable demand for this preferred stock despite stronger overall market performance, indicating a cautious investor sentiment.
- Investor Sentiment Assessment: Although the rise in SF.PRC shares is modest, its stable dividend policy may attract long-term investors, particularly in times of increased market volatility, enhancing its appeal as a defensive investment.
- Morgan Stanley Bullish on Nvidia: Morgan Stanley names Nvidia a top pick, viewing the current stock price at 18x CY27 EPS as an attractive entry point, expecting market concerns about growth durability to shift to enthusiasm in the coming months.
- Barclays Downgrades Blue Owl: Barclays downgrades Blue Owl from overweight to equal weight, citing overly high market estimates and suggesting that the stock is now closer to fairly priced based on earnings growth potential.
- Piper Sandler Upgrades CrowdStrike: Piper Sandler upgrades CrowdStrike from neutral to overweight, maintaining a $520 price target, arguing that the market's bearish sentiment driven by AI narratives is overdone for a leading security platform with a strong track record.
- Goldman Sachs Upgrades Dutch Bros: Goldman Sachs upgrades Dutch Bros from neutral to buy, asserting that the market is underestimating the coffee chain's fundamental strength and competitive positioning amid a challenging coffee landscape.
- Earnings Miss: Leon's Furniture reported a fourth-quarter earnings miss, indicating challenges in the highly competitive furniture retail market, which may negatively impact investor confidence.
- Same-Store Sales Growth: Despite the earnings miss, same-store sales increased, suggesting that the company still possesses market appeal in attracting existing customers, potentially laying the groundwork for future performance recovery.
- Intensifying Market Competition: The furniture industry is facing intensified competition, and Leon's Furniture must implement effective strategies to counter pressure from other retailers to maintain its market share.
- Increased Investor Scrutiny: With the earnings miss, investors will likely pay closer attention to the company's future performance, potentially prompting management to take measures to improve financial health and enhance shareholder value.
- Stifel's Legal Challenge: Stifel, Nicolaus is contesting a magistrate judge's recommendation regarding a financial award.
- Arbitration Panel Decision: The brokerage firm is appealing a $132.5 million payment that was mandated by an arbitration panel last year.









